You have full text access to this OnlineOpen article

Aggrenox (Asasantin retard)-induced Stevens–Johnson syndrome

  1. Tun Jao1,3,
  2. Tsung-Hua Tsai2,
  3. Jiann-Shing Jeng4

Article first published online: 24 NOV 2008

DOI: 10.1111/j.1365-2125.2008.03340.x

Issue

British Journal of Clinical Pharmacology

British Journal of Clinical Pharmacology

Volume 67, Issue 2, pages 264–265, February 2009

Additional Information

How to Cite

Jao, T., Tsai, T.-H. and Jeng, J.-S. (2009), Aggrenox (Asasantin retard)-induced Stevens–Johnson syndrome. British Journal of Clinical Pharmacology, 67: 264–265. doi: 10.1111/j.1365-2125.2008.03340.x

Author Information

  1. 1

    Section of Neurology, Department of Internal Medicine,

  2. 2

    Department of Dermatology, Far Eastern Memorial Hospital,

  3. 3

    Graduate Institute of Biomedical Electronics and Bioinformatics, National Taiwan University and

  4. 4

    Stroke Centre and Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan

*Jiann-Shing Jeng, MD, PhD, Department of Neurology, National Taiwan University Hospital, No 7 Chung-Shan South Road, Taipei 100, Taiwan. E-mail: jsjeng@ntu.edu.tw

Publication History

  1. Issue published online: 23 FEB 2009
  2. Article first published online: 24 NOV 2008
  3. RECEIVED 17 August 2008 ; ACCEPTED 29 October 2008

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (237K)

No abstract is available for this article.

View Full Article (HTML) Get PDF (237K)